LOLLINI, PIER LUIGI
LOLLINI, PIER LUIGI
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
Lollini P.-L.; Pier L Lollini; Pier-Luigi Lollini; Pierluigi Lollini; P. LOLLINI; P.L. LOLLINI
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
2025 Ruzzi, Francesca; Riccardo, Federica; Conti, Laura; Tarone, Lidia; Semprini, Maria Sofia; Bolli, Elisabetta; Barutello, Giuseppina; Quaglino, Elena; Lollini, Pier-Luigi; Cavallo, Federica
Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic Approaches
2025 Landuzzi, L; Ruzzi, F; Lollini, Pl; Scotlandi, K
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)
2025 Angelicola, Stefania; Giunchi, Francesca; Ruzzi, Francesca; Frascino, Mariateresa; Pitzalis, Mary; Scalambra, Laura; Semprini, Maria Sofia; Pittino, Olga Maria; Cappello, Chiara; Siracusa, Irene; Chillico, Ilaria Candida; Di Noia, Martina; Turato, Cristian; De Siervi, Silvia; Lescai, Francesco; Ciavattini, Teresa; Lopatriello, Giulia; Bertoli, Luca; De Jonge, Hugo; Iamele, Luisa; Altimari, Annalisa; Gruppioni, Elisa; Ardizzoni, Andrea; Rossato, Marzia; Gelsomino, Francesco; Lollini, Pier-Luigi; Palladini, Arianna
Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma
2025 Scalambra, Laura; Ruzzi, Francesca; Pittino, Olga Maria; Semprini, Maria Sofia; Cappello, Chiara; Angelicola, Stefania; Palladini, Arianna; Nanni, Patrizia; Goksøyr, Louise; Fougeroux, Cyrielle; Penichet, Manuel L; Sander, Adam Frederik; Lollini, Pier-Luigi
Vaccines for cancer prevention and treatment
2025 Cavallo, Federica; Lollini, Pier-Luigi
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape
2024 Pasello M.; Laginestra M.A.; Manara M.C.; Landuzzi L.; Ruzzi F.; Maioli M.; Pellegrini E.; De Feo A.; Lollini P.-L.; Scotlandi K.
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations
2024 Di Federico, Alessandro; Angelicola, Stefania; Frascino, Mariateresa; Siracusa, Irene; Bisanti, Beatrice; Ruzzi, Francesca; Semprini, Maria Sofia; De Jonge, Hugo; De Giglio, Andrea; Sperandi, Francesca; Brocchi, Stefano; Melotti, Barbara; Giunchi, Francesca; Gruppioni, Elisa; Altimari, Annalisa; Lollini, Pier-Luigi; Ardizzoni, Andrea; Palladini, Arianna; Gelsomino, Francesco
Engagement of CD99 activates distinct programs in Ewing sarcoma and macrophages
2024 Manara, Maria Cristina; Manferdini, Cristina; Cristalli, Camilla; Carrabotta, Marianna; Santi, Spartaco; De Feo, Alessandra; Caldoni, Giulia; Pasello, Michela; Landuzzi, Lorena; Lollini, Pier-Luigi; Salamanna, Francesca; Dominici, Sabrina; Fiori, Valentina; Magnani, Mauro; Lisignoli, Gina; Scotlandi, Katia
Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assay
2024 Ruzzi F.; Semprini M.S.; Scalambra L.; Angelicola S.; Cappello C.; Pittino O.M.; Nanni P.; Palladini A.; Lollini P.L.
IL-1 Family Members in Bone Sarcomas
2024 Lorena Landuzzi, Francesca Ruzzi, Evelin Pellegrini, Pier-Luigi Lollini, Katia Scotlandi, Maria Cristina Manara
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?
2024 Ruzzi, Francesca; Cappello, Chiara; Semprini, Maria Sofia; Scalambra, Laura; Angelicola, Stefania; Pittino, Olga Maria; Landuzzi, Lorena; Palladini, Arianna; Nanni, Patrizia; Lollini, Pier-Luigi
Programmable Release of Chemotherapeutics from Ferrocene-Based Injectable Hydrogels Slows Melanoma Growth
2024 Rothe, R.; Xu, Y.; Wodtke, J.; Brandt, F.; Meister, S.; Laube, M.; Lollini, P. -L.; Zhang, Y.; Pietzsch, J.; Hauser, S.
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience
2023 Setola, Elisabetta; Benini, S; Righi, A; Gamberi, G; Carretta, E; Ferrari, C; Avnet, S; Palmerini, E; Magagnoli, G; Gambarotti, M; Lollini, P L; Cesari, M; Cocchi, S; Paioli, A; Longhi, A; Scotlandi, K; Laginestra, M A; Donati, D M; Baldini, N; Ibrahim, T
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma
2023 Landuzzi L.; Manara M.C.; Pazzaglia L.; Lollini P.L.; Scotlandi K.
Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis
2023 Ruzzi, F; Palladini, A; Clemmensen, S; Strobaek, A; Buijs, N; Domeyer, T; Dorosz, J; Soroka, V; Grzadziela, D; Rasmussen, CJ; Nielsen, IB; Soegaard, M; Semprini, MS; Scalambra, L; Angelicola, S; Landuzzi, L; Lollini, PL; Thorn, M
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research
2023 Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, Katia Scotlandi
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
2023 Ruzzi F.; Semprini M.S.; Scalambra L.; Palladini A.; Angelicola S.; Cappello C.; Pittino O.M.; Nanni P.; Lollini P.-L.
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
2022 Pasello, Michela; Giudice, Anna Maria; Cristalli, Camilla; Manara, Maria Cristina; Mancarella, Caterina; Parra, Alessandro; Serra, Massimo; Magagnoli, Giovanna; Cidre-Aranaz, Florencia; Grünewald, Thomas G P; Bini, Carla; Lollini, Pier-Luigi; Longhi, Alessandra; Donati, Davide Maria; Scotlandi, Katia
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC
2022 Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; Scalambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
2022 Pasello, Michela; Giudice, Anna Maria; Cristalli, Camilla; Manara, Maria Cristina; Mancarella, Caterina; Parra, Alessandro; Serra, Massimo; Magagnoli, Giovanna; Cidre-Aranaz, Florencia; Grünewald, Thomas G P; Bini, Carla; Lollini, Pier-Luigi; Longhi, Alessandra; Donati, Davide Maria; Scotlandi, Katia
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Cancer vaccines: Target antigens, vaccine platforms and preclinical models | Ruzzi, Francesca; Riccardo, Federica; Conti, Laura; Tarone, Lidia; Semprini, Maria Sofia; Bolli, ...Elisabetta; Barutello, Giuseppina; Quaglino, Elena; Lollini, Pier-Luigi; Cavallo, Federica | 2025-01-01 | MOLECULAR ASPECTS OF MEDICINE | - | 1.01 Articolo in rivista | Vax Review MAM.pdf |
| Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic Approaches | Landuzzi, L; Ruzzi, F; Lollini, Pl; Scotlandi, K | 2025-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | Chondrosarcoma review ijms-26-01542.pdf |
| PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD) | Angelicola, Stefania; Giunchi, Francesca; Ruzzi, Francesca; Frascino, Mariateresa; Pitzalis, Mary...; Scalambra, Laura; Semprini, Maria Sofia; Pittino, Olga Maria; Cappello, Chiara; Siracusa, Irene; Chillico, Ilaria Candida; Di Noia, Martina; Turato, Cristian; De Siervi, Silvia; Lescai, Francesco; Ciavattini, Teresa; Lopatriello, Giulia; Bertoli, Luca; De Jonge, Hugo; Iamele, Luisa; Altimari, Annalisa; Gruppioni, Elisa; Ardizzoni, Andrea; Rossato, Marzia; Gelsomino, Francesco; Lollini, Pier-Luigi; Palladini, Arianna | 2025-01-01 | JOURNAL OF TRANSLATIONAL MEDICINE | - | 1.01 Articolo in rivista | Hyperprog NSCLC JTranslMed.pdf; 12967_2024_6023_MOESM3_ESM.zip |
| Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma | Scalambra, Laura; Ruzzi, Francesca; Pittino, Olga Maria; Semprini, Maria Sofia; Cappello, Chiara;... Angelicola, Stefania; Palladini, Arianna; Nanni, Patrizia; Goksøyr, Louise; Fougeroux, Cyrielle; Penichet, Manuel L; Sander, Adam Frederik; Lollini, Pier-Luigi | 2025-01-01 | JOURNAL OF TRANSLATIONAL MEDICINE | - | 1.01 Articolo in rivista | PCSK9 JTranslMed.pdf; 12967_2025_6126_MOESM1_ESM.docx |
| Vaccines for cancer prevention and treatment | Cavallo, Federica; Lollini, Pier-Luigi | 2025-01-01 | MOLECULAR ASPECTS OF MEDICINE | - | 1.01 Articolo in rivista | - |
| CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape | Pasello M.; Laginestra M.A.; Manara M.C.; Landuzzi L.; Ruzzi F.; Maioli M.; Pellegrini E.; De Feo... A.; Lollini P.-L.; Scotlandi K. | 2024-01-01 | JOURNAL OF CELL COMMUNICATION AND SIGNALING | - | 1.01 Articolo in rivista | Journal of Cell Communication and Signaling - 2024 - Pasello - CD99 contributes to the EWS FLI1 transcriptome by.pdf |
| Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations | Di Federico, Alessandro; Angelicola, Stefania; Frascino, Mariateresa; Siracusa, Irene; Bisanti, B...eatrice; Ruzzi, Francesca; Semprini, Maria Sofia; De Jonge, Hugo; De Giglio, Andrea; Sperandi, Francesca; Brocchi, Stefano; Melotti, Barbara; Giunchi, Francesca; Gruppioni, Elisa; Altimari, Annalisa; Lollini, Pier-Luigi; Ardizzoni, Andrea; Palladini, Arianna; Gelsomino, Francesco | 2024-01-01 | JCO PRECISION ONCOLOGY | - | 1.01 Articolo in rivista | di-federico-et-al-2024-clinical-and-preclinical-activity-of-egfr-tyrosine-kinase-inhibitors-in-non-small-cell-lung.pdf; ds_po.24.00240.xlsx |
| Engagement of CD99 activates distinct programs in Ewing sarcoma and macrophages | Manara, Maria Cristina; Manferdini, Cristina; Cristalli, Camilla; Carrabotta, Marianna; Santi, Sp...artaco; De Feo, Alessandra; Caldoni, Giulia; Pasello, Michela; Landuzzi, Lorena; Lollini, Pier-Luigi; Salamanna, Francesca; Dominici, Sabrina; Fiori, Valentina; Magnani, Mauro; Lisignoli, Gina; Scotlandi, Katia | 2024-01-01 | CANCER IMMUNOLOGY RESEARCH | - | 1.01 Articolo in rivista | CD99 Mac cir-23-0440 opt.pdf |
| Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assay | Ruzzi F.; Semprini M.S.; Scalambra L.; Angelicola S.; Cappello C.; Pittino O.M.; Nanni P.; Pallad...ini A.; Lollini P.L. | 2024-01-01 | METHODS IN CELL BIOLOGY | - | 1.01 Articolo in rivista | - |
| IL-1 Family Members in Bone Sarcomas | Lorena Landuzzi, Francesca Ruzzi, Evelin Pellegrini, Pier-Luigi Lollini, Katia Scotlandi, Maria C...ristina Manara | 2024-01-01 | CELLS | - | 1.01 Articolo in rivista | IL-1 review Cells 2024.pdf |
| Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes? | Ruzzi, Francesca; Cappello, Chiara; Semprini, Maria Sofia; Scalambra, Laura; Angelicola, Stefania...; Pittino, Olga Maria; Landuzzi, Lorena; Palladini, Arianna; Nanni, Patrizia; Lollini, Pier-Luigi | 2024-01-01 | CELL COMMUNICATION AND SIGNALING | - | 1.01 Articolo in rivista | Lipid rafts review.pdf |
| Programmable Release of Chemotherapeutics from Ferrocene-Based Injectable Hydrogels Slows Melanoma Growth | Rothe, R.; Xu, Y.; Wodtke, J.; Brandt, F.; Meister, S.; Laube, M.; Lollini, P. -L.; Zhang, Y.; Pi...etzsch, J.; Hauser, S. | 2024-01-01 | ADVANCED HEALTHCARE MATERIALS | - | 1.01 Articolo in rivista | Adv Healthcare Materials - 2024 - Rothe - Programmable Release of Chemotherapeutics from Ferrocene‐Based Injectable.pdf; adhm202400265-sup-0001-suppmat.zip |
| IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience | Setola, Elisabetta; Benini, S; Righi, A; Gamberi, G; Carretta, E; Ferrari, C; Avnet, S; Palmerini..., E; Magagnoli, G; Gambarotti, M; Lollini, P L; Cesari, M; Cocchi, S; Paioli, A; Longhi, A; Scotlandi, K; Laginestra, M A; Donati, D M; Baldini, N; Ibrahim, T | 2023-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | Setola Chondrosarcomapdf.pdf |
| Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma | Landuzzi L.; Manara M.C.; Pazzaglia L.; Lollini P.L.; Scotlandi K. | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | Synovial review 2 cancers-15-03887-v3.pdf |
| Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis | Ruzzi, F; Palladini, A; Clemmensen, S; Strobaek, A; Buijs, N; Domeyer, T; Dorosz, J; Soroka, V; G...rzadziela, D; Rasmussen, CJ; Nielsen, IB; Soegaard, M; Semprini, MS; Scalambra, L; Angelicola, S; Landuzzi, L; Lollini, PL; Thorn, M | 2023-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research | Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, Katia Scotlandi | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | Synovial cancers-15-00588.pdf |
| Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy | Ruzzi F.; Semprini M.S.; Scalambra L.; Palladini A.; Angelicola S.; Cappello C.; Pittino O.M.; Na...nni P.; Lollini P.-L. | 2023-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | VLP Review ijms-24-12963-v2.pdf |
| ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis | Pasello, Michela; Giudice, Anna Maria; Cristalli, Camilla; Manara, Maria Cristina; Mancarella, Ca...terina; Parra, Alessandro; Serra, Massimo; Magagnoli, Giovanna; Cidre-Aranaz, Florencia; Grünewald, Thomas G P; Bini, Carla; Lollini, Pier-Luigi; Longhi, Alessandra; Donati, Davide Maria; Scotlandi, Katia | 2022-01-01 | CELLULAR ONCOLOGY | - | 1.01 Articolo in rivista | ABCA6 Cellular Oncology.pdf; 13402_2022_713_MOESM9_ESM.zip |
| ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC | Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; S...calambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna | 2022-01-01 | TRANSLATIONAL LUNG CANCER RESEARCH | - | 1.01 Articolo in rivista | ADK-VR2 TLCR.pdf; tlcr-11-11-2216-coif.zip |
| Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis | Pasello, Michela; Giudice, Anna Maria; Cristalli, Camilla; Manara, Maria Cristina; Mancarella, Ca...terina; Parra, Alessandro; Serra, Massimo; Magagnoli, Giovanna; Cidre-Aranaz, Florencia; Grünewald, Thomas G P; Bini, Carla; Lollini, Pier-Luigi; Longhi, Alessandra; Donati, Davide Maria; Scotlandi, Katia | 2022-01-01 | CELLULAR ONCOLOGY | - | 1.01 Articolo in rivista | s13402-022-00735-z.pdf |